Ikarian Capital’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.71M | Buy |
233,464
+83,482
| +56% | +$2.76M | 1.48% | 12 |
|
|
2025
Q1 | $6.03M | Hold |
149,982
| – | – | 0.74% | 18 |
|
|
2024
Q4 | $7.06M | Sell |
149,982
-20,165
| -12% | -$949K | 0.96% | 14 |
|
|
2024
Q3 | $8.98M | Hold |
170,147
| – | – | 1.25% | 10 |
|
|
2024
Q2 | $9.22M | Buy |
170,147
+25,000
| +17% | +$1.35M | 1.61% | 9 |
|
|
2024
Q1 | $10.2M | Buy |
145,147
+115,147
| +384% | +$8.07M | 1.12% | 10 |
|
|
2023
Q4 | $2.5M | Buy |
+30,000
| New | +$2.5M | 0.23% | 35 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 97 |
|
|
2023
Q2 | – | Sell |
-55,666
| Closed | -$1.96M | – | 99 |
|
|
2023
Q1 | $1.96M | Buy |
+55,666
| New | +$1.96M | 0.44% | 37 |
|
|
2021
Q3 | – | Sell |
-120,895
| Closed | -$2.39M | – | 164 |
|
|
2021
Q2 | $2.39M | Sell |
120,895
-6,105
| -5% | -$121K | 0.19% | 75 |
|
|
2021
Q1 | $2.95M | Sell |
127,000
-100,000
| -44% | -$2.33M | 0.1% | 80 |
|
|
2020
Q4 | $4.72M | Buy |
227,000
+172,000
| +313% | +$3.57M | 0.21% | 40 |
|
|
2020
Q3 | $1.19M | Buy |
+55,000
| New | +$1.19M | 0.09% | 69 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 101 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 90 |
|